Riluzole - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Riluzole



  
 Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions -- Galer et al. 55 (7): 971 -- ...
Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions
Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions -- Galer et al.
of riluzole in the treatment of peripheral neuropathic pain
http://www.neurology.org/cgi/content/abstract/55/7/971

  
 Riluzole, L3
The deterioration of muscle strength and functional ability was significantly slower in the riluzole group than in the placebo group.
Discontinuation of treatment resulted in worsened chorea, indicating that riluzole was indeed associated with the improved chorea.
A secondary test used to examine the drug’s effectiveness was change in muscle strength.
http://www.stanford.edu/group/hopes/treatmts/antiglut/l3.html

  
 Rilutek , SPC from the eMC
In rats, riluzole decreased the pregnancy rate and the number of implantations at exposure levels at least twice the systemic exposure of humans given clinical therapy.
On the basis of these data, and taking into consideration the negative studies on the carcinogenesis of riluzole in the mouse and rat, the genotoxic effect of this metabolite is not considered to be of relevance in humans.
Survival, as defined in the second paragraph of section 4.1, was significantly extended for patients who received riluzole as compared to patients who received placebo.
http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=1672

  
 Treatment of Patients with ALS: Implications for the Managed Care Pharmacist
The provision of riluzole, palliative medications, and supportive care, combined with the ethical issues of mechanical ventilation and end-of-life planning, are aspects of ALS treatment to which the pharmacist and the other members of the team apply their knowledge and experience to improve patient outcomes and quality of life.
Participation in the optimal management of patients with ALS by encouraging early riluzole therapy and applying other pharmacotherapeutic principles is an example of how pharmacists can be proactive, aggressive, and clinically adept in meeting these challenges.
Most of the drugs used to treat cancer are tested in clinical trials that use survival as a primary endpoint, because surrogate markers for incurable chronic conditions are suboptimal for monitoring purposes.
http://www.amcp.org/data/jmcp/vol4/num6/treatment.html

  
 Bibliography: Rhone-Poulenc Rorer & Basal Gang
Riluzole effect on post -traumatic spinal cord injury in the rat.
This study evaluated treatment with riluzole, a neuroprotective agent, following thoracic spinal cord compression in the rat.
Morphological studies revealed significant (53%) reduction in the degree of spinal cord infarcted after riluzole treatment.
http://www.sm.u-bordeaux2.fr/gross/biblio/bibrp.html

  
 amyotrophic lateral sclerosis
We conclude that riluzole therapy improves UMN integrity in patients with ALS within weeks of initiating therapy.
Increases in the concentration of NAA within neurons may also be contributing to the observed increases in NAA after riluzole therapy.
Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy
http://www.mrs.mni.mcgill.ca/mrs/als.html

  
 Riluzole - Wikipedia, the free encyclopedia
Riluzole is a drug used to treat amyotrophic lateral sclerosis.
There were no data on quality of life, but patients treated with riluzole remained in a more moderately affected health state significantly longer than placebo-treated patients.
Approximately 10% of patients experience side effects such as nausea and fatigue which lead them to discontinue treatment.
http://en.wikipedia.org/wiki/Riluzole

  
 Involvement of Human CYP1A Isoenzymes in the Metabolism and Drug Interactions of Riluzole In Vitro -- Sanderink et al. ...
Characterization of the CYP isoenzymes responsible for the metabolism of riluzole is of importance in assessing the likelihood
Metabolic pathways involved in phase I biotransformation of riluzole.
Inhibition by riluzole of methoxyresorufin O-demethylation by yeast microsomes expressing human CYP1A2.
http://jpet.aspetjournals.org/cgi/content/full/282/3/1465

  
 PROCEEDINGS ON RILUTEK (RILUZOLE) Conference Transcript - MDA Ask the Experts
First: Will be Riluzole therapy with other therapies in the future?
A little more than five years ago, when Rhone-Poulenc Rorer began investigating whether its novel compound, then known within the neurological community as riluzole, might be useful in ALS, experts in the medical community were already amassing a convincing body of evidence linking a buildup in glutamate, at least in part, to ALS.
That same hard work and persistence by so many people has brought us where we are today, introducing Rilutek, which represents an important step forward in the understanding and treatment of ALS.
http://www.mdausa.org/experts/tr-alsrpr.html

  
 Exec Summary Vol. 5: No. 2. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a ...
Studies were included if they had investigated either clinical effectiveness, cost-effectiveness or safety of riluzole, or quality of life/patient satisfaction associated with its use in MND patients, with no restrictions on age or sex.
Patients should be made aware that riluzole does not cure ALS; accurate patient information is essential.
Even under the most optimistic assumptions, riluzole at best only postpones death for a few months, and does not preclude the need for supportive care and practical help.
http://www.hta.nhsweb.nhs.uk/execsumm/summ502.htm

  
 Riluzole for Motor Neurone Disease - full guidance (html)
5.3 In the latter stages of their disease, patients may wish to review their continued use of riluzole and they should be provided with the opportunity to discontinue treatment, if after discussion with the responsible clinician, they consider it appropriate.
This guidance does not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Motor Neurone Disease (MND) is the name given to a group of diseases that affect the motor neurones in the brain and spinal cord.
http://www.nice.org.uk/page.aspx?o=14490

  
 Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the ...
Note that the effects of riluzole on thermal hyperalgesia and mechanical allodynia lasted at least several days after its discontinuation on postoperative day 5, indicating a significant role of regulating GT uptake activity in the development of neuropathic pain behaviors in CCI rats.
Effects of riluzole on the induction of neuropathic pain behaviors
Hammer NA, Lilleso J, Pedersen JL, Kehlet H (1999) Effect of riluzole on acute pain and hyperalgesia in humans.
http://www.jneurosci.org/cgi/content/full/23/7/2899

  
 Differential Action of Riluzole on Tetrodotoxin-Sensitive and Tetrodotoxin-Resistant Sodium Channels -- Song et al. 282 ...
Riluzole is a neuroprotective drug that has antiischemic, sedative and antiepileptic properties (Malgouris et al.
Riluzole does not interact with any of the known ligand
Huang, C.-S., Nagata, K., Yeh, J. and Narahashi, T.: Riluzole, a neuroprotective drug, blocks calcium channels in rat dorsal root ganglion neurons.
http://jpet.aspetjournals.org/cgi/content/full/282/2/707

  
 Riluzole (Systemic)
Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of riluzole in children with use in other age groups.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do.
Tell your doctor and pharmacist if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
http://allnutritionals.com/drugs/r/riluzole-systemic.shtml

  
 Rilutek - Drugs & Vitamins - Drug Library - DrugDigest
Cigarette smoke can affect the amount of riluzole in your body.
Ask your prescriber or health care professional for ways to help you stop smoking or drinking.
Check with your health care professional before stopping or starting any of your medicines.
http://www.drugdigest.org/DD/DVH/Uses/0,3915,594Rilutek,00.html

  
 Drug Directory: Riluzole
Riluzole affects muscles and nerves in the body.
Your doctor may want you to have blood tests during treatment with riluzole.
Your pharmacist has additional information about riluzole written for health professionals that you may read.
http://netpediatrics.com/drugs/r-17.htm

  
 Riluzole-Sensitive Slowly Inactivating Sodium Current in Rat Suprachiasmatic Nucleus Neurons -- Kononenko et al. 91 ...
Second, the effectiveness of riluzole on the riluzole-sensitive
of SCN neuronal firing in circadian behavior of mammals, riluzole
Details of experiment are similar to those presented in A.
http://jn.physiology.org/cgi/content/full/91/2/710

  
 Riluzole
The deterioration of the muscles governing crucial body functions--especially swallowing and breathing--eventually proves fatal.
Consult your doctor for specific advice if you are taking any other prescription or over-the-counter medication.
Do not drive or engage in hazardous work until you determine how this medication affects you.
http://www.wholehealthmd.com/print/view/1,1560,DR_546,00.html

  
 MedlinePlus Drug Information: Riluzole
tell your doctor and pharmacist if you are allergic to riluzole or any other drugs.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Your doctor will order certain lab tests to check your response to riluzole.
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a696013.html

  
 NEJM -- A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
(6 of 17) with placebo and 73 percent (11 of 15) with riluzole
of muscle strength was significantly slower in the riluzole
Quality of life in motor neurone disease--towards a more practical assessment tool?.
http://content.nejm.org/cgi/content/abstract/330/9/585

  
 Families of SMA: Riluzole and SMA
A Phase I therapeutic trial should be first carried out to determine whether riluzole is well tolerated in infants.
"Our goal was to know whether riluzole, a drug able to protect neurons, might have a therapeutic benefit in SMA.
No significant improvement of motor behavior was however observed.
http://www.fsma.org/melki2003-2.shtml

  
 The management of motor neurone disease -- Leigh et al. 74 (Supplement 4): 32 -- Journal of Neurology, Neurosurgery, ...
Riluzole was safe, with a low incidence of adverse
The outcome of this study was a trend towards increased survival
(for example, riluzole) can be outlined, and the need for assessments
http://jnnp.bmjjournals.com/cgi/content/full/74/suppl_4/iv32

  
 The Use of Riluzole in the Treatment of Amyotrophic Lateral Sclerosis (Motor Neurone Disease)
However, further work should be undertaken to identify sub-groups of patients who would benefit significantly from treatment, either on the basis of a further analysis of the clinical trial data, or from other on-going primary research.
Prior to the introduction of riluzole, only symptomatic and supportive care has been available.
The cost of treatment is about £3,700 per patient year.
http://www.shef.ac.uk/uni/academic/R-Z/tiwgap/summs/GN9703.htm

  
 Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole -- Lang-Lazdunski et al. 18 (2): ...
Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole -- Lang-Lazdunski et al.
Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole
Conclusions : Riluzole may protect the spinal cord
http://ejcts.ctsnetjournals.org/cgi/content/abstract/18/2/174

  
 Dosage effects of riluzole in Huntington's disease: A multicenter placebo-controlled study -- Huntington Study Group 61 ...
Riluzole did not improve other motor, cognitive, behavioral,
Dosage effects of riluzole in Huntington's disease: A multicenter placebo-controlled study -- Huntington Study Group 61 (11): 1551 -- Neurology
Conclusions: Over 8 weeks of treatment, riluzole 200 mg/day
http://www.neurology.org/cgi/content/abstract/61/11/1551

  
 RILUZOLE
Riluzole may extend a patient's survival time and delay the need for surgery for complications.
Treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), a motor neuron disorder that causes weakness and atrophy of the muscles.
Instructions to take on an empty stomach mean 1 hour before or 2 hours after eating.
http://www.nextmd.com/DRUGS/RILUZOLE.asp

  
 Riluzole appears to minimally improve survival in ALS
The patient has read about anti-glutamatergic and anti-excitotoxicity therapy and wishes to pursue this avenue.
Paper 2 : A 155 patient 12 month multicentred double-blinded placebo-controlled trial of riluzole 100mg/day.
Riluzole does not appear to slow rate of decline of patient functional assessments
http://www.uwo.ca/cns/ebn/CATs/nm-als-therapy.htm

  
 riluzole
The imaging will allow researchers to see the condition of the nerve terminals in the brain that release dopamine.
Early-stage patients taking L-dopa or other Parkinson's drugs can be considered for the study if they stop their medication one month prior to entering the study.
In a pilot study at Baylor, riluzole appeared to be well tolerated by Parkinson's patients.
http://www.bcm.edu/pa/riluzole.htm

  
 FDA APPROVES FIRST DRUG FOR LOU GEHRIG'S DISEASE
"This is a modest effect, but before riluzole there was no therapy for ALS at all," the Secretary said.
Adverse effects of riluzole observed in clinical tests include weakness, nausea, vomiting and elevated liver enzymes.
Commenting on the approval, Secretary of Health and Human Services Donna E. Shalala noted that when tested in two placebo- controlled studies on more than 1,000 patients, riluzole prolonged survival on average by about three months.
http://www.fda.gov/bbs/topics/NEWS/NEW00522.html

  
 RILUZOLE (By mouth)
Your doctor will tell you how much medicine to use and how often.
There may be other brand names for this medicine.
You should not use this medicine if you have had an allergic reaction to riluzole.
http://www.medformation.com/ac/mm_qd.nsf/qd/dnx0873.htm

  
 Weeks of June 14, 21 and 28, 1998
While a cure for this devastating disease seems distant, the hope is that eventually a combination of drugs will be effective in halting the progression of the condition.
It is being studied both as single treatment and in combination with an existing medication for ALS, riluzole.
The other, known at this point by its experimental compound designation SR57746A, appears to enhance the body's nerve growth factors, thereby theoretically improving the survival of the remaining motor neurons and promoting nerve cell regeneration.
http://www.breakthroughtv.com/program19.htm

  
 The ALS Newsletter 4-3 MDA
The article, however, became a "shot heard 'round the world!" ALS Web sites and on-line publications quickly picked up the story, alarming readers with messages such as "Anyone taking riluzole should be aware of the following" and "ALS Medical Alert," followed by a summary of the French story.
Williams said RPR is well aware of the drug's potential to cause liver damage and that this is reflected in the labeling for the drug, which all physicians should have.
In reality, Rhone-Poulenc Rorer, maker of riluzole (brand name Rilutek), and most doctors who prescribe it for people with ALS, have been aware of riluzole's potential to cause liver damage ever since the drug was first approved by the Food and Drug Administration in late 1995.
http://www.mdausa.org/publications/als/als4_3.html

  
 .:: the jack orchard als foundation > current treatments > rilutek ::.
A confirmatory dose-ranging study of riluzole in ALS.
Riluzole appears to be more effective in patients with bulbar-onset than for those with limb-onset.
[Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
http://www.jackorchard.org/2_rilutek.asp

  
 Canadian Pharmacy, Canada Drugs, Online Pharmacy Prescriptions
Rilutek is comes in the category of drugs called also Riluzole.
Rilutek is belongs to the family of drugs known as Neuroprotective drug and commonly used to slow the progress of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Rilutek is being manufactured by Rhone-Poulenc Rorer Pharmaceuticals and is available in 50mg Tablets.
http://www.abconlinepharmacy.com/ns/customer/product2363-c-p1

  
 Hereditary Disease Foundation Riluzole Dosing in HD (RID HD)
The RID-HD study is currently enrolling subjects who have early HD at sites in the US and Canada.
The Riluzole Dosing in HD (RID-HD) study is designed to access riluzole's short term impact on motor, cognitive and behavioral symptoms of HD and to gather information on the safety and tolerability of Riluzole.
Hereditary Disease Foundation Riluzole Dosing in HD (RID HD)
http://www.hdfoundation.org/clinical/rid.html

  
 Clinical Trial: Riluzole to Treat Depression in Bipolar Disorder
Preliminary findings of a study using riluzole to treat acute depression in patients with unipolar depression indicate that it may have antidepressant properties in some patients.
This study will examine the safety and effectiveness of riluzole (Rilutek trademark) for short-term treatment of depression symptoms, such as depressed mood, psychomotor retardation, and excessive sleeping in patients with bipolar disease.
Clinical Trial: Riluzole to Treat Depression in Bipolar Disorder
http://clinicaltrials.gov/show/NCT00054704

  
 publications
Kalra S, Cashman N, Genge A, Arnold DL: Recovery of N-acetylaspartate in Corticomotor Neurons of Patients with ALS after Riluzole Therapy.
http://www.mrs.mni.mcgill.ca/mrs/publications.html

  
 Riluzole
Riluzole - Familydoctor.org - Information for patients in English and Spanish.
http://www.iseekhealth.com/pharmacy/riluzole-5715.htm

  
 Neurosciences Report - Riluzole
Researchers at the Maxine Dunitz Neurosurgical Institute are performing preclinical studies on the effect of Riluzole in an animal xenograft GBM model.
The MDNSI team is developing a clinical protocol to administer Riluzole to patients with recurrent GBM and anaplastic astrocytoma (AA) to determine its effects on tumor growth and survival among patients with AA or GBM.
One such glutamate antagonist candidate for brain tumor treatment is Riluzole, which has been approved by the U.S. Food and Drug Administration for the treatment of amyotrophic lateral sclerosis (ALS), that acts by inhibiting voltage-activated sodium channel to block glutamate release.
http://www.csmc.edu/3987.html

  
 MSN Encarta - Search Results - riluzole
Two medications may provide some relief to people with ALS.
In 1995 the Food and Drug Administration (FDA) approved riluzole, the first drug shown to...
Search Amazon.com for books about your topic, "riluzole"
http://encarta.msn.com/riluzole.html

  
 Re: riluzole
Riluzole is a new treatment that was recently approved by the FDA for the treatment of some forms of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease).
It has been shown to delay the deterioration of the neurological condition due to the ALS process.
: If they have not ruled out ALS, possibly Lymes disease, would riluzole be a proper medication to try?
http://www.medhelp.org/perl6/neuro/archive/4803.html

  
 e-solutions for health - The Health Network Company © 2003
Several therapeutic agents have recently been tested in clinical trials in patients with ALS.
Anti-glutamate agents - Riluzole, which is a sodium channel blocker that inhibits the release of glutamate and has several other potentially neuro-protective effects; it had a modest effect in prolonging survival of patients.
Antioxidant agents - no significant positive effects have been found.
http://www.thnc.com/healthguide/article.asp?id=173

  
 MedlinePlus Medical Encyclopedia: Amyotrophic lateral sclerosis
Blood tests can exclude other conditions that may cause similar symptoms.
Riluzole may prolong life, but does not reverse or stop disease progression.
Baclofen or diazepam may be used to control spasticity that interferes with activities of daily living.
http://www.nlm.nih.gov/medlineplus/ency/article/000688.htm

  
 Riluzole Dosage, Interactions, Side Effects, How to Use
Clearance of riluzole in Japanese clients is 50% lower compared with Caucasians; clearance may also be lower in women.
Use with caution in the elderly, as age-related changes in renal and hepatic function may cause a decreased clearance.
Safety and efficacy have not been determined in children.
http://www.healthdigest.org/drugs/nursing/riluzole.php

  
 Riluzole
Riluzole and she has been feeling much better over the past 4 months no more nausea etc. I was
wondering if anyone else was experiencing these symptoms of nausea who are on the Riluzole
I have only been taking it for 2 months and have had no nausea but some gas and indigestion.
http://www.als.ca/_forum/alstopic.php?t=158

  
 Rilutek ALS Info: Rilutek® Fact Sheet
Now that you and your physician have chosen Rilutek® (Riluzole) Tablets, you may have some questions about your treatment.
Although researchers don’t fully understand how Rilutek works, one explanation is that Rilutek may protect nerve cells from overexposure to glutamate.
For any questions about Rilutek that are not answered here, contact the Aventis Pharmaceuticals Drug Information Center at (610)454-8110 or 1 (800) 340-7502.
http://www.alsinfo.com/patients/RilutekPatientFactSheet.jsp

  
 riluzole
I think that my question would be concerning riluzole, That if no diagnosis can be obtained confirming ALS, but the symptoms are prevelant; fisiculations, weakness, etc., why can't a gp prescribe the medication; or can they??
When drug are released by the FDA they are to be used for specific disease entities.
http://www.medhelp.org/perl6/neuro/archive/4873.html

  
 API Synonym... RILUZOLE
Compare Internet Pharmacies - We recommend that you check with each pharmacy to see if they do business in your country and state.
If you do not see the VIPPS seal, contact the pharmacy and ask if they are taking steps to receive the VIPPS certification.
Riluzole Tablets, 50 mg, Impax, ANDA 76-173 7/17/02 Riluzole Tablets, 50 mg, Impax, ANDA 76-173
http://www.betterchem.com/drugs/RILUZOLE

  
 [Brainlife] Riluzole
, PhD, and Asha Das, MD Riluzole: A Potent Anti-Brain Tumor Agent?
Summer 2003 issue of Neurosciences Report (Review Article, HTML Full Text)
http://www.brainlife.org/treatment/riluzole.htm

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.